These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35655237)

  • 1. SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.
    Azami M; Moradi Y; Moradkhani A; Aghaei A
    Eur J Med Res; 2022 Jun; 27(1):81. PubMed ID: 35655237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
    Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.
    He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA
    J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on SARS-CoV-2 seroprevalence: regional and worldwide.
    Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.
    Hajissa K; Islam MA; Hassan SA; Zaidah AR; Ismail N; Mohamed Z
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.
    Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM
    EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.
    Liang Y; Sun Q; Liu Q; Pang Y; Tang S
    Front Public Health; 2023; 11():1044788. PubMed ID: 37900041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.
    Kayı İ; Madran B; Keske Ş; Karanfil Ö; Arribas JR; Psheniсhnaya N; Petrosillo N; Gönen M; Ergönül Ö
    Clin Microbiol Infect; 2021 Sep; 27(9):1242-1249. PubMed ID: 34116205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021.
    Lewis HC; Ware H; Whelan M; Subissi L; Li Z; Ma X; Nardone A; Valenciano M; Cheng B; Noel K; Cao C; Yanes-Lane M; Herring BL; Talisuna A; Ngoy N; Balde T; Clifton D; Van Kerkhove MD; Buckeridge D; Bobrovitz N; Okeibunor J; Arora RK; Bergeri I;
    BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35998978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term evaluation of the seroprevalence of SARS-CoV-2 IgG and IgM antibodies in recovered patients: a meta-analysis.
    Li Q; Chen L; Li F; He A
    BMC Infect Dis; 2023 Jul; 23(1):444. PubMed ID: 37393304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.
    Chisale MRO; Ramazanu S; Mwale SE; Kumwenda P; Chipeta M; Kaminga AC; Nkhata O; Nyambalo B; Chavura E; Mbakaya BC
    Rev Med Virol; 2022 Mar; 32(2):e2271. PubMed ID: 34228851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis.
    Figueiredo GM; Tengan FM; Campos SR; Luna EJ
    Clinics (Sao Paulo); 2023; 78():100233. PubMed ID: 37348256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review.
    Vaselli NM; Hungerford D; Shenton B; Khashkhusha A; Cunliffe NA; French N
    PLoS One; 2021; 16(11):e0250541. PubMed ID: 34727115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare workers highly affected during the COVID-19 epidemic wave in Poland prior to vaccination availability: seroprevalence study.
    Rosińska M; Stępień M; Kitowska W; Milczarek M; Juszczyk G; Nowacka Z; Gardel A; Hermann A; Bardoń-Błaszkowska A; Cudnik R; Czubak H; Wolniak-Bińkowska M; Źródłowska IA; Sadkowska-Todys M
    Med Pr; 2022 Apr; 73(2):109-123. PubMed ID: 35301511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
    Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
    BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.